Literature DB >> 15362980

C-terminal splicing of NTPDase2 provides distinctive catalytic properties, cellular distribution and enzyme regulation.

Carol J H Wang1, Srdjan M Vlajkovic, Gary D Housley, Norbert Braun, Herbert Zimmermann, Simon C Robson, Jean Sévigny, Christian Soeller, Peter R Thorne.   

Abstract

The present study provides functional characterization of alternative splicing of the NTPDase2 (ecto-nucleoside triphosphate diphosphohydrolase-2) involved in the regulation of extracellular nucleotide concentrations in a range of organ systems. A novel NTPDase2beta isoform produced by alternative splicing of the rat NTPDase2 gene provides an extended intracellular C-terminus and distinguishes itself from NTPDase2alpha isoform in gaining several intracellular protein kinase CK2 (casein kinase 2) phosphorylation sites and losing the intracellular protein kinase C motif. The plasmids containing NTPDase2alpha or NTPDase2beta cDNA were used to stably transfect Chinese-hamster ovary-S cells. Imaging studies showed that NTPDase2alpha was predominantly membrane-bound, whereas NTPDase2beta had combined cell surface and intracellular localization. alpha and beta isoforms showed variations in divalent cation dependence and substrate specificity for nucleoside-5'-triphosphates and nucleoside-5'-diphosphates. NTPDase2beta exhibited reduced ATPase activity and no apparent ADPase activity. NTPDase2 isoforms demonstrated similar sensitivity to inhibitors such as suramin and pyridoxal phosphate-6-azophenyl-2',4'-disulphonic acid, and differential regulation by protein kinases. NTPDase2beta was up-regulated by intracellular protein kinase CK2 phosphorylation, whereas NTPDase2alpha activity was down-regulated by protein kinase C phosphorylation. The results demonstrate that alternative coding of the intracellular C-terminal domain contributes distinctive phenotypic variation with respect to extracellular nucleotide specificity, hydrolysis kinetics, protein kinase-dependent intracellular regulation and protein trafficking. These findings advance the molecular physiology of this enzyme system by characterizing the contribution of the C-terminal domain to many of the enzyme's signature properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15362980      PMCID: PMC1134748          DOI: 10.1042/BJ20040852

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

Review 1.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

Authors:  Eduardo R Lazarowski; Richard C Boucher; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

Review 2.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

Review 3.  Is there a basis for distinguishing two types of P2-purinoceptor?

Authors:  G Burnstock; C Kennedy
Journal:  Gen Pharmacol       Date:  1985

Review 4.  Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

Authors:  T Hunter
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

5.  Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum.

Authors:  N W Seidler; I Jona; M Vegh; A Martonosi
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

6.  Differential effect on inositol-phospholipid hydrolysis, cytosolic-free Ca2+ concentration, protein kinase C activity and protein phosphorylation of 1-oleoyl-2-acetyl-sn-glycerol growth-stimulated ascites tumor cells.

Authors:  S Seibicke; J B Strosznajder; E W Haeffner
Journal:  Eur J Cell Biol       Date:  1988-08       Impact factor: 4.492

7.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

Authors:  G Martiny-Baron; M G Kazanietz; H Mischak; P M Blumberg; G Kochs; H Hug; D Marmé; C Schächtele
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

8.  Association of the ecto-ATPase NTPDase2 with glial cells of the peripheral nervous system.

Authors:  Norbert Braun; Jean Sévigny; Simon C Robson; Klaus Hammer; Menachem Hanani; Herbert Zimmermann
Journal:  Glia       Date:  2004-01-15       Impact factor: 7.452

Review 9.  Ecto-ATPases: identities and functions.

Authors:  L Plesner
Journal:  Int Rev Cytol       Date:  1995

Review 10.  Ecto-enzymes: physiology meets pathology.

Authors:  J W Goding
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

View more
  10 in total

Review 1.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

2.  The GDA1_CD39 superfamily: NTPDases with diverse functions.

Authors:  Aileen F Knowles
Journal:  Purinergic Signal       Date:  2011-01-21       Impact factor: 3.765

3.  Rat submandibular glands secrete nanovesicles with NTPDase and 5'-nucleotidase activities.

Authors:  Débora A González; Patricia Egido; Noelia B Balcarcel; Claude Hattab; Martín M Barbieri van Haaster; Julie Pelletier; Jean Sévigny; Mariano A Ostuni
Journal:  Purinergic Signal       Date:  2014-12-19       Impact factor: 3.765

Review 4.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

5.  Proline residues link the active site to transmembrane domain movements in human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3).

Authors:  Keith J Gaddie; Terence L Kirley
Journal:  Purinergic Signal       Date:  2010-03-30       Impact factor: 3.765

6.  Characterization of an alternative splice variant of human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): a possible modulator of nucleotidase activity and purinergic signaling.

Authors:  Patrick A Crawford; Keith J Gaddie; Thomas M Smith; Terence L Kirley
Journal:  Arch Biochem Biophys       Date:  2006-11-10       Impact factor: 4.013

7.  Expression of Ectonucleoside Triphosphate Diphosphohydrolase 2 (NTPDase2) Is Negatively Regulated Under Neuroinflammatory Conditions In Vivo and In Vitro.

Authors:  Milorad Dragic; Katarina Mihajlovic; Marija Adzic; Marija Jakovljevic; Marina Zaric Kontic; Nataša Mitrović; Danijela Laketa; Irena Lavrnja; Markus Kipp; Ivana Grković; Nadezda Nedeljkovic
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

8.  Transient changes in the localization and activity of ecto-nucleotidases in rat hippocampus following lipopolysaccharide treatment.

Authors:  Agnes Kittel; Beata Sperlágh; Julie Pelletier; Jean Sévigny; Terence L Kirley
Journal:  Int J Dev Neurosci       Date:  2007-05-17       Impact factor: 2.457

9.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.

Authors:  Simon C Robson; Jean Sévigny; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

10.  Plasmodium falciparum GFP-E-NTPDase expression at the intraerythrocytic stages and its inhibition blocks the development of the human malaria parasite.

Authors:  Lucas Borges-Pereira; Kamila Anna Meissner; Carsten Wrenger; Célia R S Garcia
Journal:  Purinergic Signal       Date:  2017-03-11       Impact factor: 3.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.